PCN34 Comparative Effectiveness of Docetaxel and Paclitaxel in Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Previous Chemotherapy: Propensity Score-Matching Analyses from Attraction-3 Trial

2021 ◽  
Vol 24 ◽  
pp. S24
Author(s):  
M.K. Siddiqui ◽  
J. Gricar ◽  
M. Kurt
Sign in / Sign up

Export Citation Format

Share Document